Cataplex and Pancreatrophin Recalled Due to Salmonella Threat

Posted on

Three different dietary supplements are being recalled because of the threat they could each pose to the health of those who ingest the items.

The Palmyra, Wisconsin-based Standard Process announced the recall, which encompasses Cataplex C, Cataplex ACP, and Pancreatrophin, with all three being from one specific lot (Lot 114).  Cataplex C will have a product number of 1650 1655, ACP has a number of 0700 or 0750, and the Pancreatrophin has the product number 6650.  Each of the items has a Use By date of May 2013, and this information can be found on either the 60 cc and 200 cc amber bottles that contain the supplement or the box that holds the bottles.

The problem stems from an inspection from the Food and Drug Administration which turned up a potential salmonella contamination in one of the ingredients that comprises the products.  Salmonella, which children, the elderly, and people with compromised immune systems are particularly susceptible to, can lead otherwise healthy individuals to incur diarrhea, start vomiting, and in certain serious instances, be inflicted with infections of the arteries such as arthritis.

The good news is that no reports of someone experiencing such an illness have come to the company’s attention at this point.  Standard Process has stated that they have since tested samples of the supplements, and those samples tested negative for salmonella.  However, because the threat might still exist, people with the item in their possession should bring it back to where it was bought to get their money back.